ELV Q2 2024 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q2 2024 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$43.6B-0.1% YoY

Gross Profit

$13.1B30.0% margin

Operating Income

$3.0B6.9% margin

Net Income

$2.3B5.3% margin

EPS (Diluted)

$9.85

QoQ Revenue Growth

+2.5%

Cash Flow

Operating Cash Flow

$447M

Free Cash Flow

$124M

Stock-Based Comp.

$92M

Balance Sheet

Total Assets

$113.0B

Total Liabilities

$70.7B

Stockholders' Equity

$42.2B

Cash & Equivalents

$6.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43.6B	$43.7B	-0.1%
Gross Profit	$13.1B	$12.1B	+8.3%
Operating Income	$3.0B	$2.7B	+12.0%
Net Income	$2.3B	$1.9B	+24.1%

Revenue Segments

Health Benefits Segment

$37.2B58%

Carelon Services Segment

$26.6B42%